The Union has been leading the way in knowledge and research sharing around COVID-19 and lung health, including a powerful webinar series, publishing guidance, briefings, journal articles, and a set of frequently asked questions.
FAQs on COVID-19 and lung health
The Union has published a set of frequently asked questions regarding COVID-19 and lung health, focusing on its impact on TB services and the people undergoing TB treatment, and guidance to maintain quality care throughout this period, as well as recommendations and guidance for healthcare workers treating smokers with COVID-19.
Webinar series: COVID-19 and lung health
The COVID-19 pandemic is perhaps the greatest healthcare challenge of a generation. The Union, in collaboration with its global community of members, is pleased to launch an open-access webinar series on COVID-19 and its intersection with tuberculosis (TB), tobacco control, lung disease and more.
See our other webinars here
The rationale for cancer to be made a notifiable disease in India
In this Short Communication (to be published in the Q2 issue of PHA), the authors explain why the Ministry of Health in India should make cancer a notifiable disease.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.
COVID official guidance
Read official guidance from The Union and our partner organisations on the latest guidance on COVID-19.
IJTLD fast-tracked articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking accepted articles from the International Journal of Tuberculosis and Lung Disease (IJTLD) regarding COVID-19 and publishing them in full on our website, prior to their publication in the Journal.
See a complete list of all of our fast-tracked articles here.
The rationale for cancer to be made a notifiable disease in India
In this Short Communication (to be published in the Q2 issue of PHA), the authors explain why the Ministry of Health in India should make cancer a notifiable disease.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.
The latest Union news about COVID-19
The rationale for cancer to be made a notifiable disease in India
In this Short Communication (to be published in the Q2 issue of PHA), the authors explain why the Ministry of Health in India should make cancer a notifiable disease.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.
Partner sponsored content
The Union presents a series of special webinar sessions, organised and paid for by our partners to showcase new science and new areas of work. All paid for sessions are reviewed for compliance with The Union’s mission and vision.
Past webinar
The twin epidemics of TB and COVID-19: challenges and controversies
Watch a recording of this webinar
This webinar is paid for and created by Oxford Immunotec.
